Possibility of non-steroidal treatment in allergic conjunctival diseases

Allergology International

Volumn 53, Issue 4, 2004, Pages 315-319

  Uchio, Eiichi ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Allergic conjunctival disease; Corticosteroid; Immunosuppressive agent; Non steroidal anti inflammatory drug; Vernal keratoconjunctivitis

Indexed keywords

AMLEXANOX; ANTIALLERGIC AGENT; APAFANT; AZELASTINE; BETAMETHASONE; BROMFENAC; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOSPORIN A; DEXAMETHASONE; DICLOFENAC; EMEDASTINE; EYE DROPS; IBUDILAST; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; KETOTIFEN FUMARATE; LEVOCABASTINE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; OZAGREL; PEMIROLAST; PRANLUKAST; PRANOPROFEN; PREDNISOLONE; SERATRODAST; SUPLATAST TOSYLATE; TACROLIMUS; TAZANOLAST; TRANILAST;

ALLERGIC CONJUNCTIVITIS; ANTIINFLAMMATORY ACTIVITY; ATOPIC KERATOCONJUNCTIVITIS; CLINICAL FEATURE; CORNEA INJURY; DISEASE CONTROL; DISEASE DURATION; DISEASE SEVERITY; DRUG ACTIVITY; EPIDEMIOLOGICAL DATA; GIANT PAPILLARY CONJUNCTIVITIS; GLAUCOMA; HUMAN; JAPAN; KERATOCONJUNCTIVITIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEASONAL VARIATION; VERNAL CONJUNCTIVITIS;

EID: 11144333516     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1592.2004.00349.x     Document Type: Review

References (21)

1. Allergic Conjunctival Disease Study Group. Epidemiology of allergic conjunctival diseases. Nihon-no Ganka 1997; 68: 23-31.
2. Uchio E, Ohno S. Recent progress in the diagnosis and treatment of pollinosis and allergic conjunctival diseases. Asian Med. J. 1998; 41: 555-60.
3. BenEzra D. Guidelines on the diagnosis and treatment of conjunctivitis. Ocul. Immunol. Inflamm. 1994; 2: 17-26.
4. Smolin G, O'Connor GR. Ocular Immunology, 2nd edn. Boston: Little Brown. 1986.
5. Fujishima H, Takeuchi T, Shinozaki N, Saito I, Tsubota K. Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Clin. Exp. Immunol. 1995; 102: 395-8.
6. Uchio E, Miyakawa K, Ikezawa Z, Ohno S. Systemic and local immunological features of atopic dermatitis patients with ocular complications. Br. J. Ophthalmol. 1998; 82: 82-7.
7. Yamaya H, Basaki Y, Togawa M, Kojima M, Kiniwa M, Matsuura N. Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by anti-allergic drugs. Life Sci. 1995; 56: 1647-54.
8. 2 synthetase inhibitor, OKY-046, on sputum in chronic bronchitis and diffuse panbronchitis. Eur. Respir. J. 1995; 8: 1705-11.
9. 2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in asthmatic subjects. J. Allergy Clin. Immunol. 1991; 87: 23-7.
10. Nakagawa N, Obata T, Kobayashi T et al. Effect of a peptide leukotriene receptor antagonist, ONO-1078, on guinea-pig models of asthma. Eur. J. Pharmacol. 1993; 235: 211-19.
11. Bonini S, Lambiase A, Bonini S, Levi-Schaffer F, Aloe L. Nerve growth factor: An important molecule in allergic inflammation and tissue remodeling. Int. Arch. Allergy Immunol. 1999; 118: 159-62.
12. Jerndal T, Munkby M. Corticosteroid response in dominant congenital glaucoma. Acta Ophthalmol. 1978; 56: 373-83.
13. Leonardi A, Borghesan F, Faggian D, Secchi A, Plebani M. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy 1995; 50: 610-13.
14. Leonardi A, DeFranchis G, Fregona IA, Violato D, Plebani M, Secchi AG. Effects of cyclosporin A on human conjunctival fibroblasts. Arch. Ophthalmol 2001; 119: 1512-17.
15. Laibovitz RA, Koester J, Schaich L, Reaves TA. Safety and efficacy of diclofenac sodium 0.1% ophthalmic solution in acute seasonal allergic conjunctivitis. J. Ocul. Pharmacol. Ther. 1995; 11: 361-8.
16. Gupta S, Khurana AK, Ahluwalia BK, Gupta NC. Topical indomethacin for vernal keratoconjunctivitis. Acta Ophthalmol. 1991; 69: 95-8.
17. Tauber J, Raizman MB, Ostrov CS et al. A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis. J. Ocul. Pharmacol. Ther. 1998; 14: 137-45.
18. Friedlaender M. Overview of ocular allergy treatment. Curr. Allergy Asthma Rep. 2001; 1: 375-9.
19. Friedlaender MH. The current and future therapy of allergic conjunctivitis. Curr. Opin. Ophthalmol. 1998; 9: 54-8.
20. Sharir M. Exacerbation of asthma by topical diclofenac. Arch. Ophthalmol. 1997; 115: 294-5.
21. Sheehan GJ, Kutzner MR, Chin WD. Acute asthma attack due to ophthalmic indomethacin. Ann. Intern. Med. 1989; 111: 337-8.